Cosmos Holdings Inc. (COSM) Dividend History

Cosmos Holdings Inc. (COSM) is a diversified company engaged in the acquisition, development, and commercialization of consumer brands and related businesses. The company focuses on building a portfolio of innovative products across various sectors, including health and wellness, consumer goods, and other lifestyle categories.

5 Agiou Georgiou, Pilea, Thessaloniki, J3, 55438
Phone: 312-536-3102
Website: https://www.cosmoshealthinc.com

Dividend History

Cosmos Holdings Inc. currently does not pay dividends

Company News

Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000

Cosmos Health CEO Greg Siokas has increased his stake in the company by acquiring over 1.4 million shares worth $526,000 in the past week, and over 2.7 million shares worth $1.3 million in the past five months, demonstrating his confidence in the company's future.

GlobeNewswire Inc.
Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.

Virax Biolabs has extended its exclusive distribution agreement with Cosmos Health to commercialize Mpox Virus Real-Time PCR Detection Kits in the Gulf Cooperation Council countries. The kits have high sensitivity and specificity and can deliver results in under 70 minutes.

Benzinga

Featured Companies: VRAX
Cosmos Health secures new pharma manufacturing deals - Investing.com

Cosmos Health's subsidiary Cana Laboratories has expanded its contract manufacturing portfolio with additional agreements with Provident Pharmaceuticals, involving the production of several pharmaceutical products.

Investing.com
Cosmos Health subsidiary secures Australian CBD product deal By Investing.com - Investing.com

Cosmos Health's subsidiary Cana Laboratories has entered into a contract manufacturing agreement with Australia's Humacology to produce up to 500,000 units of Humacology's CBD products. This follows Cana's recent deal with Provident Pharmaceuticals to manufacture 4.32 million units of a vitamin D product, highlighting Cosmos Health's focus on expanding its high-margin contract manufacturing business.

Investing.com
MediWound (MDWD) Reports Q1 Loss, Tops Revenue Estimates

MediWound (MDWD) delivered earnings and revenue surprises of 2.50% and 6.82%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research

Featured Companies: MDWD

Dividend data last updated 06/07/2025 08:37:11 UTC